Colonial Trust Advisors’s Moderna MRNA Stock Holding History

Colonial Trust Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Buy	+100	New	+$5.17K	﹤0.01%	625
2025 Q4	–	Sell	-50	Closed	-$1.29K	–	729
2025 Q3	$1.29K	Buy	+50	New	+$1.4K	﹤0.01%	633
2024 Q2	–	Sell	-7	Closed	-$746	–	934
2024 Q1	$746	Sell	7 -10	-59%	-$1.01K	﹤0.01%	882
2023 Q4	$1.69K	Buy	17 +14	+467%	+$1.18K	﹤0.01%	727
2023 Q3	$310	Sell	3 -7	-70%	-$781	﹤0.01%	851
2023 Q2	$1.22K	Sell	10 -9	-47%	-$1.2K	﹤0.01%	782
2023 Q1	$2.92K	Sell	19 -4	-17%	-$660	﹤0.01%	684
2022 Q4	$4.13K	Buy	+23	New	+$3.76K	﹤0.01%	644

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Colonial Trust Advisors's MRNA Position: Q2 2026 in Review

Colonial Trust Advisors opened a new position in Moderna (MRNA) in Q2 2026: 100 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #625 among its holdings. This is a return to the name: Colonial Trust Advisors previously reported a position in MRNA as recently as Q3 2025.

Colonial Trust Advisors first reported a position in MRNA in Q4 2022 and has held it in 8 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Colonial Trust Advisors held 100 shares of Moderna worth $7K as of Q2 2026.
Moderna was a new Colonial Trust Advisors position in Q2 2026.
Moderna made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #625 holding.
Colonial Trust Advisors first reported a position in Moderna in Q4 2022 and has held it in 8 quarters since.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.